Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter.
Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 355
Appendix B
Biographical Sketches of
Committee Members
Irva Hertz-Picciotto (Chair), is a professor in the Department of Public
Health Sciences, School of Medicine, and at the Medical Investigations of
Neurodevelopmental Disorders (MIND) Institute, University of California,
Davis, and is chief of the Division of Environmental and Occupational
Health. She also is deputy director of the Center for Children’s Environmen-
tal Health at UC Davis and director of the Northern California Center for
the National Children’s Study. She has published widely on environmental
exposures, including metals, pesticides, PCBs, and air pollution, and their
effects on pregnancy, the neonate, and early child development, as well as
on methods in epidemiologic research. In 2002, she turned her attention
to identifying causes of autism, and launched the CHARGE Study (Child-
hood Autism Risk from Genetics and the Environment) and subsequently
the MARBLES Study (Markers of Autism Risk in Babies–Learning Early
Signs). She has served or currently sits on editorial boards for the American
Journal of Epidemiology, Environmental Health Perspectives, Epidemiol-
ogy, and Autism Research. Dr. Hertz-Picciotto has served as president of
the Society for Epidemiologic Research and of the International Society for
Environmental Epidemiology. She has held appointments on the Governor’s
Carcinogen Identification Committee for the State of California, the sci-
entific advisory boards/panels for the Environmental Protection Agency,
National Institute for Occupational Safety and Health, National Toxicology
Program, and National Institutes of Health Interagency Coordinating Com-
mittee on Autism Research. Dr. Hertz-Picciotto has also chaired two previ-
ous Institute of Medicine committees. She received a Ph.D. and an M.P.H.
in epidemiology and an M.A. in biostatistics from UC Berkeley. Before
355
OCR for page 356
356 BREAST CANCER AND THE ENVIRONMENT
joining the faculty at UC Davis, Dr. Hertz-Picciotto was a professor in the
Department of Epidemiology at the School of Public Health, University of
North Carolina, Chapel Hill.
Lucile Adams-Campbell joined the Georgetown University Lombardi Com-
prehensive Cancer Center in 2008 as associate dean for Community Health
and Outreach. Previously, she had served as director of the Howard Univer-
sity Cancer Center for 13 years. She also serves as the co-principal inves-
tigator for the Black Women’s Health Study. She focuses on community
outreach and community-based participatory research, particularly cancer-
related health disparities in minority populations, with an emphasis on can-
cer prevention. Her research interests include understanding the biological
basis of health disparities in those cancers that disproportionately affect
minority and underserved populations via clinical trials; cancer epidemiol-
ogy using minority cohorts; and behavioral epidemiology as it relates to
physical activity and nutrition interventions. She aims to export prevention-
based clinical trials and behavioral interventions targeting nutrition and
exercise strategies to address obesity from the laboratory setting into the
community. Dr. Adams-Campbell was elected to the Institute of Medicine
in 2008. She currently serves on the editorial board of or as a reviewer for
eight journals. Dr. Adams-Campbell received an M.S. in biomedical science
from Drexel University and a Ph.D. in epidemiology from the University of
Pittsburgh. She completed a National Institutes of Health-funded postdoc-
toral fellowship at the University of Pittsburgh.
Peggy Devine is the founder and president of Cancer Information and Sup-
port Network, an organization that seeks to increase public awareness on
all aspects of cancer, including the importance of cancer research. She served
as the multisite advocate coordinator for the American College of Radiology
Imaging Network (ACRIN) MRI/CALGB Correlative Science clinical trial
(I SPY 1); is an advocate in the University of California, San Francisco Breast
Specialized Program of Research Excellence (SPORE); and is a research
advocate consultant for many groups, including Los Alamos Laboratory,
where she serves on a Department of Defense-funded team award grant,
Breast Cancer: Catch It with Ultrasound, 2011–2015. Ms. Devine has served
as a trainer for advocacy and professional associations, including the Ameri-
can Society of Clinical Oncology Gastrointestinal Cancer, Summit Series on
Clinical Trials Advocate Training, American College of Surgeons Oncology
Group, ACRIN, and Coalition of Cancer Cooperative Groups. Ms. Devine
also sits on many advisory boards, including the National Cancer Institute’s
Office of Biorepositories and Biospecimen Research Steering Committee for
a grant entitled “Research Studies in Cancer and Normal Pre-Analytical
Variables and Their Effects on Molecular Integrity,” 2010–2014. Ms. Devine
OCR for page 357
357
APPENDIX B
has also reviewed grants for the Department of Defense, the National Can-
cer Institute, Avon, Susan G. Komen for the Cure, and the California Breast
Cancer Research Program. Ms. Devine has a B.S. in chemistry and biologi-
cal science from Michigan State University. She then completed a year of
training in clinical laboratory science at Huntington Memorial Hospital and
holds federal and state licensure in that field.
David Eaton is associate vice provost for research and a professor
in the Department of Environmental and Occupational Health Sciences
at the School of Public Health of the University of Washington. He is
also the director of the Center for Ecogenetics and Environmental Health
at the University of Washington. He joined the faculty of the University of
Washington in 1979. Dr. Eaton’s research and teaching focus on the molec-
ular basis for environmental causes of cancer, and how human genetic dif-
ferences in biotransformation enzymes may increase or decrease individual
susceptibility to chemicals found in the environment. He has served as presi-
dent of the Society of Toxicology and as a member of the board of trustees
of the Academy of Toxicological Sciences. He is an elected fellow of the
American Association for the Advancement of Science and the Academy
of Toxicological Sciences. Dr. Eaton has served on several committees for
the National Academy of Sciences, most recently chairing the Committee
for Review of the Federal Strategy to Address Environmental, Health, and
Safety Research Needs for Engineered Nanoscale Materials. He received
his Ph.D. in pharmacology and toxicology and completed a postdoctoral
fellowship in toxicology at the University of Kansas Medical Center.
S. Katharine Hammond is a professor in the Division of Environmental
Health Sciences in the School of Public Health of the University of Califor-
nia, Berkeley. Her research interests focus on health effects of exposure to
airborne materials, including responses of asthmatic children to short-term
fluctuations in particulate air pollution, neurologic and reproductive effects
of hexane on workers, secondhand smoke, and the effects of exposure to
polycyclic aromatic hydrocarbons on asthmatic children and users of coal
in China. She has received the National Institute for Occupational Safety
and Health’s Alice Hamilton Award for Excellence in Occupational Safety
and Health and the American Industrial Hygiene Association’s Rachel
Carson Environmental Award. Dr. Hammond currently serves on the Sci-
entific Review Panel on Toxic Air Contaminants for the California Envi-
ronmental Protection Agency and has served as a consultant to the Science
Advisory Board of the Environmental Protection Agency. She is also a
member of the World Health Organization’s Tobacco Product Regulation
Study Group. She has served on numerous committees for the Institute of
Medicine and the National Research Council. Dr. Hammond received a
OCR for page 358
358 BREAST CANCER AND THE ENVIRONMENT
Ph.D. in chemistry from Brandeis University and an M.S. in environmental
health sciences from the Harvard School of Public Health.
Kathy J. Helzlsouer is the director of the Prevention and Research Center at
Mercy Medical Center in Baltimore, Maryland. She is also an adjunct pro-
fessor of epidemiology at the Johns Hopkins University Bloomberg School
of Public Health. Dr. Helzlsouer’s work focuses on clinical epidemiology,
cancer epidemiology, and cancer prevention. In 2008, Dr. Helzlsouer was
named chair of the Maryland State Council on Cancer Control. She also is
chair-elect of the Molecular Epidemiology Group (MEG) of the American
Association for Cancer Research. She serves on the Physician Data Query
(PDQ) Cancer Screening and Prevention Committee of the National Cancer
Institute, and she is a member of the advisory board for the AARP Cohort
Study. Dr. Helzlsouer holds an M.D. from the University of Pittsburgh
School of Medicine and an M.H.S. in epidemiology from the Johns Hopkins
University School of Hygiene and Public Health. She is board certified in
medical oncology.
Robert A. Hiatt is professor and chair of Epidemiology and Biostatistics
at University of California, San Francisco (UCSF). He is the director of
Population Sciences and associate director of the UCSF Helen Diller Family
Comprehensive Cancer Center. Dr. Hiatt holds adjunct appointments at the
UC Berkeley School of Public Health and the Division of Research at Kaiser
Permanente Northern California. He has been the principal investigator
for the Bay Area Breast Cancer and the Environment Research Center for
the past 7 years and now leads the Coordinating Center for the national
program that continues to explore the influence of environmental factors
on pubertal maturation as a window to understanding the causes of breast
cancer. From 1998 to early 2003, Dr. Hiatt was the first deputy director
of the Division of Cancer Control and Population Sciences at the National
Cancer Institute (NCI), where he oversaw cancer research in epidemiology
and genetics, surveillance, and health services research. Before then he was
the director of Prevention Sciences at the Northern California Cancer Cen-
ter and also assistant director for epidemiology at the Division of Research,
Kaiser Permanente Medical Care Program in Northern California. He is
board certified in preventive medicine and, until taking his NCI position,
practiced general internal medicine. He is a past president of the American
College of Epidemiology and the American Society for Preventive Oncol-
ogy. Dr. Hiatt received an M.D. from the University of Michigan and a
Ph.D. in epidemiology from the University of California, Berkeley.
Chanita Hughes Halbert is an associate professor in the Department of
Psychiatry at the University of Pennsylvania and director of the Center
OCR for page 359
359
APPENDIX B
for Community-Based Research and Health Disparities. She is also direc-
tor of the Community Diversity Initiative at the Abramson Cancer Center
and associate director for Community Engagement in the Robert Wood
Johnson Clinical Scholars Program. Dr. Hughes Halbert’s research focuses
on understanding the sociocultural underpinnings of cancer prevention and
control behaviors among ethnically diverse populations and translating this
knowledge into interventions designed to reduce ethnic and racial differ-
ences in cancer morbidity and mortality. She is principal investigator (PI) of
an academic–community partnership funded by the National Institute on
Minority Health and Health Disparities and the National Cancer Institute
to develop and evaluate interventions for cancer prevention and control in
community settings. She is also PI of grants funded by the National Human
Genome Research Institute to identify barriers and facilitators of Afri-
can American participation in cancer genetics research and to understand
the long-term psychological and behavioral impact of genetic testing for
BRCA1 and BRCA2 mutations. She earned her Ph.D. in personality psy-
chology from Howard University. In addition to her doctoral training, Dr.
Hughes Halbert completed pre- and postdoctoral training at the Lombardi
Cancer Center at Georgetown University.
David J. Hunter is the dean for Academic Affairs and Vincent L. Gregory
Professor in Cancer Prevention in the Departments of Epidemiology and
Nutrition in the Harvard School of Public Health. His principal research
interests are the etiology of cancer—particularly breast, prostate, and skin
cancer. He was an investigator on the Nurses’ Health Study, a long-running
cohort of 121,000 U.S. women, and a project director for the Nurses’
Health Study II, a newer cohort of 116,000 women. He also analyzes
inherited susceptibility to cancer and other chronic diseases using molecu-
lar techniques and studies molecular markers of environmental exposures.
Dr. Hunter was the director for the Harvard Center for Cancer Prevention
and was co-director of the National Cancer Institute (NCI) Cancer Genetic
Markers of Susceptibility (CGEMS) Special Initiative. He is the director
of the Program in Molecular and Genetic Epidemiology at the Harvard
School of Public Health, and co-chair of the NCI Breast and Prostate Can-
cer Cohort Consortium. Dr. Hunter received his M.P.H. and Sc.D. from
Harvard University. He earned his M.B., B.S. from the University of Sydney.
Barnett (Barry) Kramer is editor-in-chief of the Journal of the National
Cancer Institute (JNCI) and of the Screening and Prevention Editorial
Board of the National Cancer Institute (NCI) Physician Data Query (PDQ).
He was the associate director for disease prevention and head of the Office
of Disease Prevention in the Office of the Director at the National Institutes
of Health from 2001 to 2010. Previously, he served as the director of the
OCR for page 360
360 BREAST CANCER AND THE ENVIRONMENT
Office of Medical Applications of Research (OMAR), a component of the
Office of Disease Prevention. He has also previously served as deputy direc-
tor of NCI’s Division of Cancer Prevention. Dr. Kramer received his M.D.
from the University of Maryland Medical School and is board certified in
internal medicine and medical oncology. He received an M.P.H. from the
Johns Hopkins University School of Hygiene and Public Health.
Bryan M. Langholz is a professor of research in the Division of Biosta-
tistics and a visiting professor in the department of preventive medicine
at the Keck School of Medicine of the University of Southern California
(USC). He also is a research adjunct professor in the USC Department of
Mathematics and a member of the Children’s Oncology Group. Dr. Lang-
holz’s research interests are cohort sampling methods, statistical methods
in epidemiology and occupational health, and statistical methods in genetic
epidemiology. Additionally, he has done biostatistics research in pesticides
and cancer, electromagnetic fields and cancer, radiation and cancer, and
genetic and environmental factors in type 1 diabetes. Dr. Langholz is cur-
rently a co-principal investigator on a National Cancer Institute-funded
study examining the link between ultraviolet exposure and melanogenesis.
Dr. Langholz is a member of the American Statistical Association, the
International Biometrics Society, the International Genetic Epidemiology
Society, and the International Society of Clinical Biostatistics. He has served
as a reviewer for 28 journals and was an associate editor for Biometrics.
Dr. Langholz previously served on the Institute of Medicine Committee to
Review the Health Effects in Vietnam Veterans of Exposure to Herbicides:
First Biennial Update. Dr. Langholz received an M.S. and a Ph.D. in bio-
mathematics from the University of Washington.
Peggy Reynolds is a senior research scientist at the Cancer Prevention
Institute of California, a consulting professor for the Department of Health
Research and Policy in the Stanford University School of Medicine, and a
member of the Stanford Cancer Center. Dr. Reynolds spent several years as
an epidemiologist for the California Tumor Registry and San Francisco Bay
Area SEER (Surveillance, Epidemiology, and End Results) program, and
previously served as the chief of the Environmental Epidemiology Section in
the California Department of Health Services. Over the years, she has con-
ducted a number of cancer epidemiology studies, with a concentration on
environmental risk factors. Her research currently focuses on female breast
cancer and cancers in children. She was a founding member of the Califor-
nia Teachers Study (CTS), an ongoing prospective study of 133,479 women
established in 1995. Dr. Reynolds was a co-investigator for an influential
multicenter study on the risk of lung cancer from secondhand smoke. She
and her research team further pursued the role of secondhand smoke and
OCR for page 361
361
APPENDIX B
breast cancer in a more detailed assessment of reported lifetime exposures
in the CTS. In addition, Dr. Reynolds has served as principal investigator
for a study of regional variations in breast cancer in California, a study
of body burden levels of endocrine disruptors in breast cancer patients, a
study of breast cancer in young women, studies of breast cancer incidence
in flight attendants and cosmetologists, a study of malignant melanoma
among Lawrence Livermore Laboratory employees, and a statewide study
of patterns of childhood cancer. Dr. Reynolds earned a Ph.D. in epidemiol-
ogy from the University of California, Berkeley.
Joyce S. Tsuji is a principal scientist within the Center for Toxicology and
Mechanistic Biology of the Health Sciences practice of Exponent. She is a
board-certified toxicologist and a fellow of the Academy of Toxicological
Sciences. She has conducted risk assessment and toxicology studies in the
United States and internationally for industry, trade associations, the Envi-
ronmental Protection Agency (EPA) and state agencies, the Department of
Justice, the Australian EPA, municipalities, and private citizens. Dr. Tsuji’s
experience includes human health and environmental toxicology related
to metals and a wide variety of other chemicals in the environment. She
has designed and directed dietary and environmental exposure studies and
community programs involving health education and biomonitoring for
populations potentially exposed to chemicals in the environment, includ-
ing soil, water, and food-chain exposures. She has also assessed exposure
and health risks associated with chemicals in air, foods, and a variety of
consumer products. She has served on committees for several National
Research Council (NRC) studies and is currently a member of the NRC
Board on Environmental Studies and Toxicology and the NRC Committee
on Toxicology. Dr. Tsuji received a Ph.D. in environmental physiology and
completed a postdoctoral fellowship in quantitative genetics at the Depart-
ment of Zoology of the University of Washington.
Cheryl Lyn Walker recently became a Welch Professor and director of the
Institute of Biosciences and Technology of Texas A&M Health Science
Center. Prior to this appointment, she was the Ruth and Walter Sterling Pro-
fessor of Carcinogenesis at the University of Texas MD Anderson Cancer
Center, where she also directed the Center for Environmental and Molecu-
lar Carcinogenesis of the Institute for Basic Science. Dr. Walker’s research
interests include the genetic basis of susceptibility to cancer, specifically the
interaction of environmental agents with genes during tumor development;
the effects of endocrine disruptors on human health; and animal models
for human disease. She also studies the molecular mechanisms of kidney,
breast, and uterine cancers and the mechanisms by which environmental
hormones reprogram the epigenome to increase susceptibility to these can-
OCR for page 362
362 BREAST CANCER AND THE ENVIRONMENT
cers. She has served on the Board of Scientific Counselors of the National
Cancer Institute and the National Institute of Environmental Health Sci-
ences National Toxicology Program and is a past president of the Society
of Toxicology. Dr. Walker received her Ph.D. from the Department of
Cell Biology at the University of Texas Health Science Center, Southwest-
ern Medical School (Dallas), and completed postdoctoral training at the
National Institutes of Health.
Lauren Zeise is chief of the Reproductive and Cancer Hazard Assess-
ment Branch of the California Environmental Protection Agency’s Office
of Environmental Health Hazard Assessment. She oversees or is involved
in a variety of California’s risk assessment activities, including cancer and
reproductive toxicant assessments; development of frameworks and meth-
odologies for assessing toxicity, cumulative impact, nanotechnology, green
chemistry/safer alternatives, and susceptible populations; the California
Environmental Contaminant Biomonitoring Program; and health risk char-
acterizations for environmental media, food, fuels and consumer products.
Dr. Zeise’s research focuses on human interindividual variability, dose
response, uncertainty, and risk. She was the 2008 recipient of the Society
of Risk Analysis’s Outstanding Practitioners Award. She has served on
advisory boards and committees of the Environmental Protection Agency
(EPA), Office of Technology Assessment, World Health Organization, and
National Institute of Environmental Health Sciences. Dr. Zeise has also
served on numerous National Research Council and Institute of Medicine
committees and boards. Most recently, she was a member of the Commit-
tee to Review EPA’s Title 42 Hiring Authority for Highly Qualified Scien-
tists and Engineers, and the Committee on Use of Emerging Science for
Environmental Health Decisions. Dr. Zeise received a Ph.D. from Harvard
University.
